Becton Dickinson Receives Health Canada Authorization for the BD Veritor At-home COVID-19 Test

Becton Dickinson (BD) has been successful in their bid to have Health Canada recognize the Veritor® COVID-19 testing system as a home self-test and authorize it under Interim Order 334278.

It is unknown when the Veritor® test will be available in Canada, but moving away from the analyzer-based testing system will lower the cost barrier of entry for many people. A 84.6% testing sensitivity is not the highest positive percentage agreement (PPA) available on the Canadian market (as most are above 90%) but these tests have been distributed for months by the federal and provincial governments and have had a solid track record.